Aura Biosciences to Participate in Upcoming Investor ConferencesBusiness Wire • 2 months agoAura Biosciences Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced...